메뉴 건너뛰기




Volumn 13, Issue 2, 1999, Pages 135-142

Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression

Author keywords

Famotidine; Misoprostol; Nonsteroidal anti inflammatory drugs; Omeprazole; Peptic ulcer; Ranitidine

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE; RANITIDINE; STOMACH SECRETION INHIBITOR;

EID: 0032923371     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/715703     Document Type: Conference Paper
Times cited : (6)

References (37)
  • 1
    • 0031031977 scopus 로고    scopus 로고
    • Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking
    • Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17.
    • (1997) J Clin Gastroenterol , vol.24 , pp. 2-17
    • Kurata, J.H.1    Nogawa, A.N.2
  • 2
    • 0030015717 scopus 로고    scopus 로고
    • Gastrointestinal tract complications of nonsteroidal antiinflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
    • Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal antiinflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 1996;156:1530-6.
    • (1996) Arch Intern Med , vol.156 , pp. 1530-1536
    • Singh, G.1    Ramey, D.R.2    Morfeld, D.3    Shi, H.4    Hatoum, H.T.5    Fries, J.F.6
  • 3
    • 0025998097 scopus 로고
    • Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis
    • Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96.
    • (1991) Ann Intern Med , vol.115 , pp. 787-796
    • Gabriel, S.E.1    Jaakkimainen, L.2    Bombardier, C.3
  • 4
    • 0025853360 scopus 로고
    • Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons
    • Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray LA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
    • (1991) Ann Intern Med , vol.114 , pp. 257-263
    • Griffin, M.R.1    Piper, J.M.2    Daugherty, J.R.3    Snowden, M.4    Ray, L.A.5
  • 5
    • 8944227048 scopus 로고    scopus 로고
    • Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis
    • Henry D, Lim LLY, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6.
    • (1996) BMJ , vol.312 , pp. 1563-1566
    • Henry, D.1    Lim, L.L.Y.2    Garcia Rodriguez, L.A.3
  • 6
    • 0026024439 scopus 로고
    • Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers
    • Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991;32:252-5.
    • (1991) Gut , vol.32 , pp. 252-255
    • Lancaster-Smith, M.J.1    Jaderberg, M.E.2    Jackson, D.A.3
  • 7
    • 0024552757 scopus 로고
    • Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
    • Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:69-75.
    • (1989) N Engl J Med , vol.320 , pp. 69-75
    • Walan, A.1    Bader, J.P.2    Classen, M.3
  • 8
    • 0030961530 scopus 로고    scopus 로고
    • Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration
    • Hudson N, Taha AS, Russell RI, et al. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology 1997;112:1817-22.
    • (1997) Gastroenterology , vol.112 , pp. 1817-1822
    • Hudson, N.1    Taha, A.S.2    Russell, R.I.3
  • 9
    • 0024452662 scopus 로고
    • Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine
    • Daneshmend TK, Prichard PJ, Bhaskar NK, Millns PJ, Hawkey CJ. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine. Gastroenterology 1989;97:944-9.
    • (1989) Gastroenterology , vol.97 , pp. 944-949
    • Daneshmend, T.K.1    Prichard, P.J.2    Bhaskar, N.K.3    Millns, P.J.4    Hawkey, C.J.5
  • 10
    • 0023262313 scopus 로고
    • Cimetidine therapy in nonsteroidal antiinflammatory drug gastropathy. Double-blind long-term evaluation
    • Roth SH, Bennett RE, Mitchell CS, Hartman RJ. Cimetidine therapy in nonsteroidal antiinflammatory drug gastropathy. Double-blind long-term evaluation. Arch Intern Med 1987;147:1798-801.
    • (1987) Arch Intern Med , vol.147 , pp. 1798-1801
    • Roth, S.H.1    Bennett, R.E.2    Mitchell, C.S.3    Hartman, R.J.4
  • 11
    • 0022649723 scopus 로고
    • The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs
    • Davies J, Collins AJ, Dixon SA. The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs: Br J Rheumatol 1986;25:54-8.
    • (1986) Br J Rheumatol , vol.25 , pp. 54-58
    • Davies, J.1    Collins, A.J.2    Dixon, S.A.3
  • 12
    • 0023706934 scopus 로고
    • Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine
    • Ehsanullah RSB, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988;297:1017-21.
    • (1988) BMJ , vol.297 , pp. 1017-1021
    • Ehsanullah, R.S.B.1    Page, M.C.2    Tildesley, G.3    Wood, J.R.4
  • 13
    • 0024506386 scopus 로고
    • Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs
    • Robinson MG, Griffin JW Jr, Bowers J, et al. Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989;34:424-8.
    • (1989) Dig Dis Sci , vol.34 , pp. 424-428
    • Robinson, M.G.1    Griffin Jr., J.W.2    Bowers, J.3
  • 14
    • 9344236529 scopus 로고    scopus 로고
    • Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs
    • Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996;334:1435-9.
    • (1996) N Engl J Med , vol.334 , pp. 1435-1439
    • Taha, A.S.1    Hudson, N.2    Hawkey, C.J.3
  • 15
    • 0025146273 scopus 로고
    • Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine
    • Nwokolo CU, Smith JT, Gavey C, Sawyerr A, Pounder RE. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 1990;4(Suppl 1): 29-45.
    • (1990) Aliment Pharmacol Ther , vol.4 , Issue.1 SUPPL. , pp. 29-45
    • Nwokolo, C.U.1    Smith, J.T.2    Gavey, C.3    Sawyerr, A.4    Pounder, R.E.5
  • 17
    • 0031942446 scopus 로고    scopus 로고
    • Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer
    • Bianchi Porro G, Lazzaroni M, Manzionna G, Petrillo M. Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer. Aliment Pharmacol Ther 1998;12:355-60.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 355-360
    • Bianchi Porro, G.1    Lazzaroni, M.2    Manzionna, G.3    Petrillo, M.4
  • 18
    • 0032510378 scopus 로고    scopus 로고
    • Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
    • Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group
    • Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998;338:727-34.
    • (1998) N Engl J Med , vol.338 , pp. 727-734
    • Hawkey, C.J.1    Karrasch, J.A.2    Szczepanski, L.3
  • 19
    • 0032510315 scopus 로고    scopus 로고
    • A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs
    • Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group
    • Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998;338:719-26.
    • (1998) N Engl J Med , vol.338 , pp. 719-726
    • Yeomans, N.D.1    Tulassay, Z.2    Juhasz, L.3
  • 20
    • 0029162250 scopus 로고
    • Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial
    • Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9.
    • (1995) Ann Intern Med , vol.123 , pp. 241-249
    • Silverstein, F.E.1    Graham, D.Y.2    Senior, J.R.3
  • 21
    • 0027933764 scopus 로고
    • Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial
    • Elliott SL, Yeomans ND, Buchanan RR, Smallwood RA. Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial. Scand J Rheumatol 1994;23:171-6.
    • (1994) Scand J Rheumatol , vol.23 , pp. 171-176
    • Elliott, S.L.1    Yeomans, N.D.2    Buchanan, R.R.3    Smallwood, R.A.4
  • 22
    • 0025345299 scopus 로고
    • Abolition by omeprazole of aspirin induced gastric mucosal injury in man
    • Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ. Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut 1990;31:514-7.
    • (1990) Gut , vol.31 , pp. 514-517
    • Daneshmend, T.K.1    Stein, A.G.2    Bhaskar, N.K.3    Hawkey, C.J.4
  • 24
    • 0030016432 scopus 로고    scopus 로고
    • Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study
    • Ekstrom P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996;31:753-8.
    • (1996) Scand J Gastroenterol , vol.31 , pp. 753-758
    • Ekstrom, P.1    Carling, L.2    Wetterhus, S.3
  • 25
    • 0031975071 scopus 로고    scopus 로고
    • Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users
    • Cullen D, Bardhan KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 1998;12:135-40.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 135-140
    • Cullen, D.1    Bardhan, K.D.2    Eisner, M.3
  • 26
    • 0023617192 scopus 로고
    • Acid suppression in duodenal ulcer: A meta-analysis to define optimal dosing with antisecretory drugs
    • Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987;28:1120-7.
    • (1987) Gut , vol.28 , pp. 1120-1127
    • Jones, D.B.1    Howden, C.W.2    Burget, D.W.3    Kerr, G.D.4    Hunt, R.H.5
  • 27
    • 0025368161 scopus 로고
    • The relationship between suppression of acidity and gastric ulcer healing rates
    • Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther 1990;4:25-33.
    • (1990) Aliment Pharmacol Ther , vol.4 , pp. 25-33
    • Howden, C.W.1    Hunt, R.H.2
  • 28
    • 0032579940 scopus 로고    scopus 로고
    • Mechanism of action of nonsteroidal antiinflammatory drugs
    • Vane JR, Botting RM. Mechanism of action of nonsteroidal antiinflammatory drugs. Am J Med 1998;104(Suppl 3A):2S-8S.
    • (1998) Am J Med , vol.104 , Issue.SUPPL. 3A
    • Vane, J.R.1    Botting, R.M.2
  • 29
    • 0032579896 scopus 로고    scopus 로고
    • Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs
    • Schmassmann A. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104(Suppl 3A):43S-51S.
    • (1998) Am J Med , vol.104 , Issue.SUPPL. 3A
    • Schmassmann, A.1
  • 30
    • 0028968789 scopus 로고
    • Nitric oxide-releasing NSAIDS: A novel class of GI-sparing anti-inflammatory drugs
    • Wallace JL, Pittman QJ, Cirino G. Nitric oxide-releasing NSAIDS: a novel class of GI-sparing anti-inflammatory drugs. Agents Actions Suppl 1995;46:121-9.
    • (1995) Agents Actions Suppl , vol.46 , pp. 121-129
    • Wallace, J.L.1    Pittman, Q.J.2    Cirino, G.3
  • 31
    • 0008915459 scopus 로고    scopus 로고
    • Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat
    • Muscara MN, McKnight W, Del Soldato P, Wallace JL. Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat. Life Sci 1998;62:PL235-40.
    • (1998) Life Sci , vol.62
    • Muscara, M.N.1    McKnight, W.2    Del Soldato, P.3    Wallace, J.L.4
  • 32
    • 0032579891 scopus 로고    scopus 로고
    • Does Helicobacter pylori status affect nonsteroidal antiinflammatory drug-associated gastroduodenal pathology?
    • Malfertheiner P, Labenz J. Does Helicobacter pylori status affect nonsteroidal antiinflammatory drug-associated gastroduodenal pathology? Am J Med 1998;104(Suppl 3A):35S-40S.
    • (1998) Am J Med , vol.104 , Issue.SUPPL. 3A
    • Malfertheiner, P.1    Labenz, J.2
  • 33
    • 0031906022 scopus 로고    scopus 로고
    • Canadian Helicobacter pylori consensus conference
    • Canadian Association of Gastroenterology
    • Hunt RH, Thomson AB. Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. Can J Gastroenterol 1998;12:31-42.
    • (1998) Can J Gastroenterol , vol.12 , pp. 31-42
    • Hunt, R.H.1    Thomson, A.B.2
  • 34
    • 0030877226 scopus 로고    scopus 로고
    • Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
    • European Helicobacter Pylori Study Group
    • Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997;41:8-13.
    • (1997) Gut , vol.41 , pp. 8-13
  • 35
    • 0030044363 scopus 로고    scopus 로고
    • Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer
    • Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996;110:725-32.
    • (1996) Gastroenterology , vol.110 , pp. 725-732
    • Labenz, J.1    Tillenburg, B.2    Peitz, U.3
  • 36
    • 0028915876 scopus 로고
    • Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole
    • Verdú EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995;36:539-43.
    • (1995) Gut , vol.36 , pp. 539-543
    • Verdú, E.F.1    Armstrong, D.2    Fraser, R.3
  • 37
    • 0028850461 scopus 로고
    • Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole
    • Verdú EF, Armstrong D, Idström JP, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995;37:743-8.
    • (1995) Gut , vol.37 , pp. 743-748
    • Verdú, E.F.1    Armstrong, D.2    Idström, J.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.